The largest database of trusted experimental protocols

Dual energy x ray absorptiometry

Manufactured by Hologic
Sourced in United States

Dual-energy X-ray absorptiometry is a type of lab equipment used to measure bone density. It uses two different X-ray energies to determine the composition of tissue, including the amount of bone mineral content.

Automatically generated - may contain errors

33 protocols using dual energy x ray absorptiometry

1

Bone Mineral Density Measurement Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMD was measured before and after treatment. Dual energy X-ray absorptiometry (HOLOGIC, Wi, USA) was used to detect the anterior and posterior lumbar vertebrae (L1 ~ L4), left femoral neck (Neck), and Wards triangle of each subject, expressed by BMD (g/cm2). The accuracy of the instrument was 1%, and the repeated measurement error was 1%. In order to reduce the error, all testing operations were completed by the same person. Every day, the instrument was checked with the module provided by the manufacturer, and the test was carried out only after meeting the quality control requirements. The standard for judging bone mass was T score: when T > −1.0, it meant normal bone mass; when it was (−1.0, −2.5), it meant osteopenia; when T < −2.5, it meant osteoporosis [15 ].
+ Open protocol
+ Expand
2

Cardiometabolic Risk Factors Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
At each research clinic visit, participants underwent blood sampling and completed standardized questionnaires regarding medical history including current medications, smoking status, and daily alcohol consumption. Height, weight, waist circumference, and percentage of total body fat as quantified by dual-energy X-ray absorptiometry (Hologic, Waltham, MA) were measured at each visit. Hypertension was defined as a reported diagnosis and/or systolic blood pressure greater than 130 mm Hg and/or diastolic blood pressure (DBP) greater than 85 mm Hg.
Laboratory evaluation included total cholesterol, high-density lipoprotein, low-density lipoprotein, triglyceride, hemoglobin A1C, fasting glucose, serum creatinine, and aspartate aminotransferase levels. The presence of diabetes was defined by patient report of a diagnosis and/or a fasting glucose level of 126 g/dL or greater.
+ Open protocol
+ Expand
3

Assessing Bone Density Changes with Romosozumab

Check if the same lab product or an alternative is used in the 5 most similar protocols
Research procedures and equipment: Dual-energy X-ray absorptiometry (Discovery: Hologic, Waltham, MA, USA) was performed to measure the lumbar spine and femoral neck BMDs before and 6 months and 1 year after administering romosozumab. Biochemical markers of bone turnover, such as tartrate-resistant acid phosphatase-5b (TRACP-5b) and procollagen type 1 N-terminal propeptide (P1NP), were measured before and 6 months and 1 year after administering romosozumab.
+ Open protocol
+ Expand
4

Dual-energy X-ray Absorptiometry for Body Composition

Check if the same lab product or an alternative is used in the 5 most similar protocols
Body composition (fat and fat-free mass) was assessed using standard dual-energy x-ray absorptiometry (Hologic, Waltham, MA) methods [38 (link)].
+ Open protocol
+ Expand
5

Bone Density Measurement Using DXA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dual-Energy X-ray Absorptiometry (Hologic Inc., Bedford MA, U.S.A.) was used for bone densitometry. After treatment, every subject was examined on supine position to get the BMD (g/cm2) of L2∼4, neck, G.T, hip joint, Ward’s triangle, and focile.
+ Open protocol
+ Expand
6

Assessing Bone Mineral Density by DXA

Check if the same lab product or an alternative is used in the 5 most similar protocols
The dual-energy X-ray absorptiometry (Hologic, Marlborough, MA, USA) was used to assess the BMD of the participants. During the BMD measurement, participants were in the supine position. The lumbar spine (L1-L4), total hip, and femoral neck make up the BMD measurement areas. The densitometry scanning was performed by experienced radiographers who were also blinded to clinical information. T-scores were calculated according to the Hologic densitometry reference value. Longitudinal quality control checks were performed daily using whole-body and L1-L4 lumbar spine phantom provided by the manufacturer. Cross-calibration was performed weekly to monitor variations between the systems. The precision error was 1.0% for the BMD measurement. Postmenopausal women with a T score ≤ −2.5 or a history of bone fragility fractures, −2.5 < T-score ≤ −1.0, and T-score >-1.0 were considered to have osteoporosis, osteopenia, and normal BDM, respectively.
+ Open protocol
+ Expand
7

Ovariectomy-Induced Bone Loss in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sixteen female C57BL/6 mice (8 weeks old, mean weight of 19 g) were purchased from SLAC Laboratory Animal Company, Ltd. (Shanghai, China) and assigned randomly into two groups: the bilateral ovariectomy group (OVX) and the sham operation control group. The mice were anesthetized with 5% ketamine and underwent bilateral ovariectomy (OVX; eight mice) or sham operation (sham; eight mice) in a bioclean environment. Skin incision was performed in both the OVX and sham groups, and the OVX group underwent ovary removal surgery. The bilateral ovaries from the sham group were identified and placed back into the abdominal cavity. The abdominal incisions were carefully sutured in both groups. The two groups of mice were housed separately with free access to food and drinking water for 12 weeks and prepared for subsequent experiments. The animal experimental procedures were approved in accordance with the Institutional Animal Care and Use Committee of Xiangya Hospital, Central South University (Changsha, Hunan, China). The mice were sacrificed 12 weeks after the operation, and dual-energy X-ray absorptiometry (Hologic, Bedford, MA, USA) was used to measure the femur bone density. Specifically, trabecular number (Tb.N) and trabecular thickness (Tb.Th) were quantified using micro-CT.
+ Open protocol
+ Expand
8

Bone Mineral Density Measurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
The BMD at lumbar vertebrae 1–4 (L1–L4), spine bone mineral density (sBMD) results summary (L2–L4), femoral neck and trochanter was measured using dual-energy x-ray absorptiometry (Hologic, Inc., Bedford, MA, USA), and BMD was calculated as the BMC divided by projected bone area. Study participants’ BMD was compared with reference BMD values from young non-diabetic subjects (T value) and with non-diabetic subjects from the same age group (Z value).
+ Open protocol
+ Expand
9

Comprehensive Body Composition and Exercise Capacity Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Body composition was determined using dual-energy x-ray absorptiometry (Hologic, Waltham, MA, USA). Quality control checks were completed daily, and all scans were performed and analyzed by the same certified densitometry technician (EH). A CPET was used to determine peak oxygen consumption (VO2peak) and exercise trial workloads. Participants completed 1-minute stages with 20 watt increases until volitional exhaustion. Expired gases were sampled every 15 s using automated gas analyzers (Moxus Modular VO2 System, AEI Technologies, Pittsburgh, PA, USA) calibrated prior to each test. VO2peak was determined as the average oxygen consumption across the last minute of the CPET. Heart rate was assessed continuously via 12 lead electrocardiogram (GE Case Cardiosoft v6.6 ECG Diagnostic Systems, Palatine, IL, USA) and rate of perceived (RPE) exertion using the original Borg scale at the end of each stage.
+ Open protocol
+ Expand
10

Osteoporosis and Lean Mass Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMD was measured at the femur and lumbar spine (L1–L4) by dual-energy X-ray absorptiometry (Hologic Corp., Bedford, MA). According to the World Health Organization criteria, osteoporosis is defined as a BMD >2.5 standard deviations below that of a healthy young population (T-score ≤–2.5).[22 (link)] Appendicular skeletal lean mass was obtained by summing the lean mass values for the upper and lower extremities, as measured by bioelectrical impedance analysis. A diagnosis of low lean mass was based on the values established by the Foundation for National Institutes of Health.[23 ] Lean mass was calculated by dividing appendicular skeletal lean mass (in kilogram) by the body mass index (BMI; the cutoff reference values were <0.512 for women and <0.789 for men).
Based on the presence of osteoporosis and the low lean mass cutoffs, participants were classified into 4 groups: control (normal BMD and normal lean mass), osteoporosis (osteoporosis and normal lean mass), low lean mass (normal BMD and low lean mass), and osteoporosis + low lean mass.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!